Titre : | Mortality among subjects previously apprehended for driving under the influence of traffic-hazardous medicinal drugs |
Titre traduit : | (Mortalité chez des sujets précédemment interpellés pour conduite de véhicules sous l'influence de psychotropes) |
Auteurs : | HAUSKEN A. M. ; S. SKURTVEIT ; A. S. CHRISTOPHERSEN |
Type de document : | Périodique |
Année de publication : | 2005 |
Format : | 423-429 / tabl. |
Note générale : |
Drug and Alcohol Dependence, 2005, 79, (3), 423-429 |
Langues: | Anglais |
Discipline : | EPI (Epidémiologie / Epidemiology) |
Mots-clés : |
Thésaurus mots-clés PSYCHOTROPES ; MEDICAMENTS ; PRODUIT ILLICITE ; ALCOOL ; CONDUITE DE VEHICULE ; FACTEUR DE RISQUE ; MORTALITE ; ETUDE LONGITUDINALEThésaurus géographique NORVEGE |
Résumé : |
ENGLISH : Background: Most studies in the field of impaired driving have focused on the hazards represented by impaired drivers to the rest of society; there has been little follow-up of the drivers themselves. The aim of this study was to establish mortality rates among subjects previously apprehended for driving under the influence of traffic-hazardous medicinal drugs, alone or in combination with alcohol. Methods: A prospective cohort study of all drivers aged 20-49 years, apprehended in Norway in 1992-1996 and testing positive for traffic-hazardous medicinal drugs in blood, outcome variable: death. Study population: 805 drivers (598 males, 207 females). Mean follow-up period : 6,8 years. Information on deaths was collected from Statistics Norway. Results: During the follow-up period, 139 of the previously apprehended drivers died (110 males, 29 females). The calculated standardised mortality ratio (SMR) was 15.8 (95 % CI: 13,0 - 19,0) for male and 20,0 (95 % CI : 13,4 - 28,7) for female drivers. Conclusions: Apprehension on suspicion of driving under the influence of drugs, combined with detection of traffic-hazardous medicinal drugs in the blood, seems to indicate an elevated risk of premature death in the age group 20 - 49 years.Secondary prevention of continued drug use could save lives in this drug user group. (Review's abstract.) |
Note de contenu : | tabl. |
Domaine : | Plusieurs produits / Several products |
Refs biblio. : | 31 |
Affiliation : |
Division of Epidemiology, Norwegian Institute of Public Health, P.O. Box 4404 Nydalen, N-0403 Oslo Norvège. Norway. |
Numéro Toxibase : | 806014 |
Centre Emetteur : | 08 CAS Strasbourg |
Exemplaires
Disponibilité |
---|
aucun exemplaire |
Accueil